-
Featured Authors
Events
Category Archives: Events
Latest From Events
The First-Ever BIO Latin America Conference a Major Success
The first-ever BIO Latin America Conference was a major success and will become an annual must-attend event for those doing business in the region. Rio de Janeiro, SEPTEMBER 2014 – The 2014 BIO Latin America Conference, held on September 9-11, in Rio de Janeiro, brought together the in-depth expertise vital to the growth of the biotech industry in Latin America, and provided the attendees with networking and programming not available at any other regional gathering. Read More >
BIO 2015 – Call for Sessions Extended
It’s not too late to submit a session proposal for the 2015 BIO International Convention. We’ve just extended the submission deadline until Wednesday, October 8th at 5:00 pm EDT. All ideas are welcome! We seek proposals that reflect current trends and novel ideas in all focus areas Business Development & Finance Biomedical Technology: Research & Development Digital Health General Biotechnology Interest Intellectual Property Value, Market Access & Commercialization View the full list here. If you’d Read More >
Gates to contribute $50M for Ebola response
Bill Gates was on MSNBC’s Morning Joe to discuss the Gates Foundation’s contribution of $50 million to support emergency response to Ebola. Mr. Gates responded to criticism that the U.S. was initially slow to properly address the African crisis. He noted that it would be virtually impossible to respond much quicker to the unprecedented scale of the outbreak. He did call upon other countries to step up and dedicate resources as well. The most recent Read More >
BIO Investor Forum Company Snapshot: Syntrix Biosystems
1. What is your company’s lead product or technology? Omnitram (O-desmethyltramadol) is a novel oral analgesic developed by Syntrix that alleviates pain via a dual mechanism involving mu-opioid receptor activation and inhibition of the reuptake of norepinephrine. Omnitram is in clinical development and has just completed a Phase 1b double-blind, placebo-controlled clinical trial (N=40) in experimental pain. 2. What sets your company apart from competitors? Omnitram is a proprietary solution for pain relief that is Read More >
Patient and Venture Philanthropy Groups Presenting at 2014 BIO Investor Forum
BIO’s alliance development team works to foster collaboration between the biotech industry and nonprofit disease foundations. In recent years, many nonprofit foundations have become more engaged in the drug development process – whether they have created clinical trial recruitment tools, established a disease registry, or funded emerging biotech companies. Recognizing the value of these initiatives to expedite research and drug development, BIO provides opportunities for venture philanthropies and patient organizations to connect with BIO members Read More >
Events
Leave a comment
Email This Post
Tags: 2014 BIO Investor Forum, BIO EVENT, BIO Investor Forum, Blood cancer research, diabetes, health, Juvenile Diabetes Research Foundation, Leukemia & Lymphoma Society, Michael J. Fox Foundationfor Parkinson’s Research, Parkinson's disease, patient, Rare Cancer Research Foundation
Tags: 2014 BIO Investor Forum, BIO EVENT, BIO Investor Forum, Blood cancer research, diabetes, health, Juvenile Diabetes Research Foundation, Leukemia & Lymphoma Society, Michael J. Fox Foundationfor Parkinson’s Research, Parkinson's disease, patient, Rare Cancer Research Foundation
